Table 5 Late deaths by treatment group
Late death after >5 years | ASCT (n/%) | MT (n/%) | P-value |
|---|---|---|---|
Intention to treat (149 ASCT/146 MT) | 0.494 | ||
By tumour | 13 (9) | 10 (7) | |
By 2nd malignancy | 0 (0) | 1 (<1) | |
By therapy for recurrence | 2 (1) | 1 (<1) | |
All | 15 (10) | 12 (8) | |
As treated (112 ASCT/102 MT) | 0.269 | ||
By tumour | 8 (7) | 5 (5) | |
By 2nd malignancy | 1 (<1) | 0 (0) | |
By therapy for recurrence | 1 (<1) | 2 (2) | |
All | 10 (9) | 7 (7) | |
Treated as randomised (77 ASCT /70 MT) | 0.795 | ||
By tumour | 4 (5) | 6 (9) | |
By 2nd malignancy | 0 (0) | 0 (0) | |
By therapy for recurrence | 1 (1) | 1 (1) | |
All | 5 (6) | 7(10) |
